Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Getinge

279.20 SEK+0.43 %19.11, 16.06
Less than 1K followers

GETI B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+0.43 %
+6.73 %
+16.04 %
+45.61 %
+27.61 %
+34.81 %
+27.37 %
-31.54 %
+3,426.00 %

Getinge is a Swedish global medical technology company specializing in providing equipment and IT systems to the healthcare and life science industries. The company offers solutions for operating rooms, intensive care units, sterilization centers, and drug development, among other things. The company was founded in 1904 and is headquartered in Gothenburg.

Read more
Market cap
76.05B SEK
Turnover
34.8M SEK
Revenue
34.97B
EBIT %
10.84 %
P/E
33.68
Dividend yield-%
1.7 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.1
2027

Annual report '26

20.4
2027

Interim report Q1'27

20.4
2027

General meeting '27

Press release12.11.2026, 12.30

Getinge establishes Sustainable Financing Framework

Getinge
Regulatory press release09.11.2026, 16.00

Getinge appoints Stacy Beske as President Acute Care Therapies

Getinge
Regulatory press release26.10.2026, 09.59

Getinge announces departure of Elin Frostehav as President Acute Care Therapies

Getinge

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Getinge, Audiocast, Q3'26
Webcast21.10.2026, 10.00

Getinge, Audiocast, Q3'26

Getinge
Regulatory press release21.10.2026, 08.00

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

Getinge
Press release16.10.2026, 15.30

Modular Finance IR Consensus: Getinge – Consensus estimates Q3 2026

Getinge
Regulatory press release15.10.2026, 09.00

Nomination Committee appointed ahead of Getinge's Annual General Meeting 2027

Getinge
Regulatory press release07.10.2026, 14.45

Getinge announces departure of Eric Honroth, President Life Science

Getinge
Press release07.10.2026, 09.00

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Getinge
Getinge, Audiocast, Q2'26
Webcast17.07.2026, 10.00

Getinge, Audiocast, Q2'26

Getinge
Regulatory press release17.07.2026, 08.00

Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow

Getinge
Press release14.07.2026, 14.00

Modular Finance IR Consensus: Getinge – Consensus estimates Q2 2026

Getinge
Press release03.07.2026, 14.46

Getinge receives refund of tariffs paid under IEEPA

Getinge
Press release03.07.2026, 09.00

Getinge invites fund managers, analysts, and media to Q2 Report 2026 conference call

Getinge
Press release02.06.2026, 15.00

Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting

Getinge
Press release28.05.2026, 18.35

Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

Getinge
Regulatory press release21.04.2026, 17.10

Resolutions at Getinge's Annual General Meeting April 21, 2026

Getinge
Getinge, Audiocast, Q1'26
Webcast21.04.2026, 13.00

Getinge, Audiocast, Q1'26

Getinge
Regulatory press release21.04.2026, 12.00

Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone

Getinge
Press release16.04.2026, 14.30

Modular Finance IR Consensus: Getinge – Consensus estimates Q1 2026

Getinge